Vivanza Biosciences Intrinsic Value

Vivanza Biosciences intrinsic value. Vivanza Biosciences (VIVANZA) median intrinsic value is ₹2.88 from 7 valuation models (range ₹1–₹4), vs current price ₹1.44 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Analyse VIVANZA shareholder distribution to track promoter, FII and institutional holdings.

Market Price (CMP)
₹1.44
Primary Intrinsic Value
₹2.64
Market Cap
₹0.6 Cr
+100.0% Upside
Median Value
₹2.88
Value Range
₹1 - ₹4
Assessment
Trading Below Calculated Value
Safety Margin
50.0%

VIVANZA Valuation Methods Summary — DCF, Graham Number & P/E

Vivanza Biosciences intrinsic value across 7 models vs current price ₹1.44 — upside/downside and value range per method. Browse VIVANZA annual financials for revenue, profit, balance sheet and cash flow data.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹2.64 ₹2.11 - ₹3.17 +83.3% EPS: ₹0.12, Sector P/E: 22x
Book Value Method asset ₹3.60 ₹3.24 - ₹3.96 +150.0% Book Value/Share: ₹10.00, P/B: 2.0x
Revenue Multiple Method revenue ₹2.88 ₹2.59 - ₹3.17 +100.0% Revenue/Share: ₹110.00, P/S: 2.0x
Simple DCF (5Y) dcf ₹3.60 ₹2.88 - ₹4.32 +150.0% CF Growth: 5.0%, Discount: 15%
PEG Ratio Method growth ₹0.77 ₹0.69 - ₹0.85 -46.5% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹1.85 ₹1.67 - ₹2.04 +28.5% Revenue Growth: 6.0%, Adj P/E: 15.5x
Graham Defensive Method conservative ₹4.32 ₹3.89 - ₹4.75 +200.0% EPS: ₹0.12, BVPS: ₹10.00
Method Types: Earnings Asset DCF Growth Dividend Conservative

VIVANZA Intrinsic Value vs Market Price — All Valuation Models

Vivanza Biosciences fair value range ₹1–₹4 vs current market price ₹1.44 across 7 valuation models. For current market price and key ratios, visit Vivanza Biosciences stock price NSE.

VIVANZA Intrinsic Value Analysis — Undervalued or Overvalued?

Vivanza Biosciences median intrinsic value ₹2.88, current price ₹1.44 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.

What is the intrinsic value of VIVANZA?

Based on our comprehensive analysis using 7 different valuation methods, the estimated intrinsic value of Vivanza Biosciences (VIVANZA) is ₹2.88 (median value). With the current market price of ₹1.44, this represents a +100.0% variance from our estimated fair value.

The valuation range spans from ₹0.77 to ₹4.32, indicating ₹0.77 - ₹4.32.

Is VIVANZA undervalued or overvalued?

Based on our multi-method analysis, Vivanza Biosciences (VIVANZA) appears to be trading below calculated value by approximately 100.0%.

VIVANZA Financial Health — Key Ratios vs Industry Benchmarks

Vivanza Biosciences financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Operating Margin 2.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 2.00x Industry Standard: 1.0x+ Above 1.0x Measures asset utilization efficiency

VIVANZA Cash Flow Quality — Operating & Free Cash Flow

Vivanza Biosciences operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹-3 Cr ₹-3 Cr Negative Cash Flow 3/10
March 2025 ₹-3 Cr ₹-3 Cr Negative Cash Flow 3/10
March 2024 ₹2 Cr ₹2 Cr Positive Free Cash Flow 8/10
March 2023 ₹-1 Cr ₹-1 Cr Negative Cash Flow 3/10
March 2022 ₹3 Cr ₹3 Cr Positive Free Cash Flow 8/10